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Abstract
The role of the NS1 protein in modulating influenza A virulence and host range was assessed by adapting A/Hong Kong/
1/1968 (H3N2) (HK-wt) to increased virulence in the mouse. Sequencing the NS genome segment of mouse-adapted
variants revealed 11 mutations in the NS1 gene and 4 in the overlapping NEP gene. Using the HK-wt virus and reverse
genetics to incorporate mutant NS gene segments, we demonstrated that all NS1 mutations were adaptive and enhanced
virus replication (up to 100 fold) in mouse cells and/or lungs. All but one NS1 mutant was associated with increased
virulence measured by survival and weight loss in the mouse. Ten of twelve NS1 mutants significantly enhanced IFN-b
antagonism to reduce the level of IFN b production relative to HK-wt in infected mouse lungs at 1 day post infection,
where 9 mutants induced viral yields in the lung that were equivalent to or significantly greater than HK-wt (up to 16 fold
increase). Eight of 12 NS1 mutants had reduced or lost the ability to bind the 30 kDa cleavage and polyadenylation
specificity factor (CPSF30) thus demonstrating a lack of correlation with reduced IFN b production. Mutant NS1 genes
resulted in increased viral mRNA transcription (10 of 12 mutants), and protein production (6 of 12 mutants) in mouse cells.
Increased transcription activity was demonstrated in the influenza mini-genome assay for 7 of 11 NS1 mutants. Although
we have shown gain-of-function properties for all mutant NS genes, the contribution of the NEP mutations to phenotypic
changes remains to be assessed. This study demonstrates that NS1 is a multifunctional virulence factor subject to adaptive
evolution.
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Introduction
Highly pathogenic avian influenza (HPAI) H5N1 viruses have
the ability to infect human hosts and cause fatal disease [1,2], with
566 reported human cases resulting in 332 deaths [3]. Currently,
the genetic determinants of influenza A virus (IAV) host
adaptation are largely unknown [4,5]. Although HPAI H5N1
has not yet acquired the property of human to human
transmission, the possibility of a pathogenic H5N1 virus becoming
fully adapted to the human host remains a threat to global health.
It is thus necessary to understand the genetic determinants of IAV
host range and virulence in order to predict the emergence of
strains with pandemic potential.
The IAV non-structural protein 1 (NS1) is expressed from the
full length transcript of gene segment 8 that overlaps with the
spliced nuclear export protein (NS2/NEP) transcript. Several
reports have demonstrated that the NS1 protein contributes to
influenza virulence and host range in animal models [5–9]. NS1
has multiple regulatory roles during IAV infection that ultimately
suppress the host interferon (IFN) antiviral responses and promote
virus replication [10]. NS1 inhibits IFN production as well as
suppresses IFN antiviral effects via numerous host factor
interactions. NS1 inhibits IFN production by interfering with the
cytoplasmic viral RNA sensor retinoic acid-inducible gene 1 (RIG-
I), both by directly binding RIG-I to block activation of IFN
mRNA transcription [11–13] and by binding the ubiquitin ligase
tripartite motif-containing protein 25 (TRIM25) that activates
RIG-I antiviral signalling [14]. NS1 also blocks IFN-induced
STAT-1 signalling to prevent IFN-stimulated gene transcription
[15]. NS1 down regulates host gene expression, including IFN
expression, by binding the cleavage and polyadenylation specificity
factor 30 F2F3 domain (CPSF30-F2F3) [16–18], polyA binding
protein nuclear 1 (PABPNI) [19], and the nuclear RNA export
factor 1/tip-associated protein (NXF1/TAP) [20], and these
interactions result in the inhibition of host mRNA processing
and/or export. NS1 also binds dsRNA and the dsRNA-dependent
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1protein kinase R (PKR) to prevent dsRNA-induced activation of
the antiviral effectors PKR and 29-59oligo(A) synthetase (29-59
OAS) [21–23].
The NS1 protein regulates viral gene expression at multiple
levels including splicing. Although NS1 was found to alter the
accumulation of segment 7 spliced mRNAs [24], the role of NS1
in gene segment 8 splicing remains unresolved; some reports have
demonstrated the splicing of segment 8 is independent of NS1
function [25,26], while others have shown NS1 blocks the splicing
of its own mRNA [27,28]. In the context of viral gene
transcription, NS1 has been found to associate with virus
ribonucleoprotein (RNP) complexes in vivo [29], and recently
Robb et al. demonstrated NS1 directly interacts with the A/WSN/
1933 (H1N1) nucleoprotein (NP) in vitro [30]. Moreover, a recent
study identified a novel interaction between NS1 and cellular
protein hnRNP-F involved in viral transcription, where depletion
of hnRNP-F increased viral RNA polymerase activity and
ultimately viral replication [31]. Several studies have shown that
the NS1 protein is required for viral RNA synthesis [23,32,33].
Moreover, NS1 interaction with the polymerase complex has been
associated with the NS1:CPSF30 complex in H5N1-infected cells
[34]. In addition to effects on viral transcription, NS1 also
enhances viral mRNA translation by direct interaction with
cellular translation initiation factors polyA binding protein 1
(PABPI) and eukaryotic initiation factor 4 GI (eIF4GI), which
directs the complex to the viral mRNA 59 untranslated region
(59UTR) to increase viral protein synthesis [35,36]. The NS1
protein is considered a major virulence factor by enhancing viral
gene expression and down regulating both host gene expression
and the IFN-mediated antiviral responses.
Mutations and deletions in the NS1 protein have been
associated with increased IAV virulence. Highly pathogenic
H5N1 viruses isolated from waterfowl, poultry, and humans in
Southeast Asia since 2000 possess a 15-nucleotide deletion from
position 263–277 in the NS gene [1,37,38], resulting in a deletion
in residues 80 to 84 that enhances virulence in both chicken and
mice [8]. Genetic analyses of other NS1 genes from highly
pathogenic H5N1 isolates, A/Goose/Guangdong/1/96 and A/
Duck/Guangxi/27/03, have shown mutations V149A and P42S
result in high virulence in chickens and mice, respectively [6,39].
Although NS1 inhibits and activates many host factors, it is not
clear which NS1 functions are the primary modulators for
adaptive differences among IAVs. In order to identify genetic
determinants for IAV virulence and host adaptation, we and
others have employed experimental evolution in a novel host to
map genetic mutations arising upon adaptation [40–44]. To this
end, we adapted the human isolate A/Hong Kong (HK)/1/1968
(H3N2) (HK-wt) to increased virulence in the mouse by serial
lung-to-lung passage [5,7,42,45,46]. Using this approach, all
mutant mouse-adapted (MA) genome segments in the virulent
A/Hong Kong/1/68-MA (HK-MA) variant demonstrated in-
creased disease severity including the NS1 V23A mutation that
decreased MLD50 by 6 fold compared to the HK-wt virus [46].
Recently, Dankar et al. (2011) reported that NS1 gene mutations
F103L and M106I selected upon mouse adaptation were
convergent with virulence determinants in the H5N1 NS1 gene
from A/HK/156/1997, and that expression of these mutations in
the HK-wt NS1 gene, as well as in the NS1 gene of the H5N1
human isolate A/HK/156/1997 and in the H9N2 chicken isolate,
A/Ck/Beijing/1/1995 increased virulence in the mouse [7]. In
the current study, we further assessed the roles of 11 MA
mutations in the NS1 gene of A/Hong Kong/1/68 (H3N2) on
host adaptation and virulence, and employed reverse genetics
using the rHK-wt backbone to demonstrate their effect on
replication and virulence in mouse cells and lungs. We found
NS1 mutations selected upon mouse adaptation were multifunc-
tional, where numerous mutations increased virulence in the
mouse, replication in vivo and in vitro, viral gene expression in vitro,
as well as enhanced properties of IFN antagonism.
Results
NS1 gene mutations identified in A/Hong Kong/1/1968
mouse adapted variants
We had previously described the experimental evolution of A/
Hong Kong/1/1968 (HK-wt) by serial passage in the mouse lung
to select highly virulent variants [5,42,45,46]. The genomes of
each mouse adapted (MA) variant were previously subjected to full
genome sequencing where each variant was found to possess
mutations in several viral genes [5]. In respect to the NS1 gene,
mouse adapted variants had acquired 11 distinct combinations of
single or double mutations within the NS1 gene, 3 of which
induced mutations in the overlapping NEP gene (Fig. 1a) [5]. The
amino acid substitutions in NS1 and NEP are reproduced here in
Figure 1a for representative NS1 mutant MA variants, in addition
to the nucleotide substitutions and Genbank accession numbers for
each genome segment. We had previously reported that all of
these MA mutants (except MA111 (MLD50.10
7.5 PFU) and
MA103 (unavailable)) had decreased MLD50 values that ranged
from 10
1.1 to 10
6.5 PFU (geometric mean=10
4.1 PFU) relative to
the non-virulent parental HK-wt that possessed an MLD50.
10
7.7 PFU [5]. Figure 1b shows the survival response of groups of
mice infected with 10
7 or 10
6 PFU of the indicated MA viruses
relative to HK-wt mice to demonstrate the increased virulence of
these MA variants that were associated with 100% mortality in all
cases except for MA111.
Generation of recombinant NS mutant Hong Kong
viruses
To determine the role of each mutant MA NS1 gene in
virulence, recombinant HK viruses were generated to express the
mutations of each mouse adapted NS gene segment (rHK NS
mutants). In addition, we generated the NS1 mutant L98S, a
mutation that was selected in combination with the M106I
mutation upon mouse adaption (MA53, Fig. 1a). rHK NS mutants
with NEP mutations (Fig. 1a) were indicated by an
{ throughout
the text. The NS gene segments of all rescued viruses were
sequenced to verify that they were free of unwanted mutations. All
rHK viruses grew to high titre (.1610
7 PFU/mL) in the allantoic
cavity of SPF chicken embryos as determined by plaque assay on
MDCK cell monolayers.
NS1 mutations selected upon mouse adaption enhance
virulence in mice
To assess the effect of NS1 mutations on virulence in mice,
groups of 5 or 6 CD-1 mice were infected intranasally with rHK-
wt as well as rHK NS mutants. High dose infection with rHK-wt
(5610
6 PFU) in mice did not result in mortality (Fig. 2a). In
contrast, 7 of the 12 NS1 mutants (D2N
{, L98S, M106V, M106I,
M106I+L98S, D125G, and V180A
{) resulted in 20% to 83%
mortality in the mouse (Fig. 2a) at the same dosage of infection.
The virus possessing the NS1 mutation D2N
{ was the most
virulent, causing 83% mortality (5 of 6 mice), and resulted in a
.30 fold reduction of MLD50 value compared to the rHK-wt
virus (10
6.2 PFU versus.10
7.7 PFU). The NS1 M106I+L98S
mutant caused 40% mortality (2 of 5 mice), whereas the single
mutants of this combination, M106I and L98S, as well as mutants
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{, all caused 20% mortality (Fig. 2a).
Although several NS1 mutants did not increase mortality, the
majority of MA NS1 mutations increased disease severity, as
measured by body weight loss. Mouse body weight loss following
infection of the rHK-wt virus reached a maximum average loss of
5%, whereas all mutants induced significantly more weight loss
than rHK-wt from days 1–6 post infection, (p-values range from
,0.05 to ,0.001; two-tailed paired, t-test), with the exception of
NS1 mutants V226I and R227K
{ that did not result in statistically
significant decreased body weight loss (Fig. 2b). The extent of body
weight loss in general correlated with mortality however the
M106I mutant virus induced the greatest weight loss but resulted
in less mortality than the two most virulent mutants, D2N
{ and
M106I+L98S, which both induced the next greatest statistically
Figure 1. MA viruses with NS mutations demonstrate enhanced virulence in the mouse. (A) Table of MA viruses indicating mutations in
the NS gene segment at the protein (aa) and mRNA level (nt) as well as MLD50 value in CD-1 mice. (B) Kill curve of MA viruses with NS mutations. CD-1
mice were infected with 1610
7 PFU dose (1610
6 PFU dose used for viruses indicated with an *) and survival was monitered for 14 days.
doi:10.1371/journal.pone.0031839.g001
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(p,0.001, two tailed, paired, t-test). In addition, all the mutants
causing fatality of 1 of 5 mice (L98S, M106I, M106V, D125G, and
V180A
{) also demonstrated a significant decrease in body weight
compared to rHK-wt from days 1–6 pi (p,0.01, p,0.05, p,0.01,
p,0.01, and p,0.05, two-tailed, paired, t-test) (Fig. 2b). These
observations show that the majority of single and double NS1
mutations acquired upon adaptation to the mouse possessed
properties of increased virulence.
NS1 mutants D2N
{, M106I, L98S and M106I+L98S
increase virus infection and pathology in the mouse lung
Given that NS1 mutants D2N
{ and M106I+L98S induced the
greatest mortality in the mouse (Fig. 2a), we assessed these
combinations of mutations as well as the single mutants L98S and
M106I for their role in lung tropism and lung pathology following
intranasal infection using a dose of 1610
5 PFU/mouse. Pathology
and extent of lung tissue infection was determined by H&E and
immunofluorescent staining of HK viral antigen, respectively, on
frozen lung sections collected 2 and 6 dpi. The rHK-wt virus
antigen was detected in focal regions in the bronchi at day 2 but
not day 6 pi, however at day 2 the NS1 mutants D2N
{, M106I,
L98S and M106I+L98S all infected bronchiolar regions to a
greater extent (Fig. 3). In addition, mutants D2N
{, L98S and
M106I+L98S increased virus spread to alveolar regions of the lung
(Fig. 3). At day 6 pi, viral antigens persisted in the mouse lung in
both alveolar and bronchiole regions for NS1 mutants M106I and
M106I+L98S (Fig. 3, white arrows). Lung pathology was mild for
rHK-wt, where H&E staining was similar to mock-infected (PBS)
lungs at day 2 pi, and moderate congestion with increased
inflammatory cell recruitment was seen for the bronchiole region
at day 6 pi (Fig. 3). Increased lung pathology including alveolar
Figure 2. Mouse adapted NS1 mutations increase virulence in CD-1 mice. Groups of 5 female CD-1 mice were infected intranasally with
5610
6 PFU dose of rHK NS MA or HK-wt virus. rHK NS1 mutant M106V + M124I was inoculated at dose of 2.5610
6 PFU due to insufficient viral stock
titre. Survival (A) and body weight loss (B) were monitored for 14 dpi. Percent body weight is expressed as the mean value of 5 (or total number alive)
mice (*p,0.05, **p,0.01, ***p,0.001; two-tailed unequal variance paired student’s t-test for days 1–6). Experimental endpoint was defined as .30%
body weight loss and respiratory distress. Graphical analysis of data was broken into three mutant sets, with rHK-wt included in each, due to the
number of mutants surveyed.
doi:10.1371/journal.pone.0031839.g002
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mutants L98S and M106I+L98S, and at 6 dpi for NS1 mu-
tants D2N
{, M106I, and M106I+L98S (Fig. 3). The enhanced
pathology and spread within the lung demonstrated increased
abilities to overcome host resistance due these NS1 mutations,
which in turn resulted in greater virus replication and disease
severity.
Mouse-adapted NS1 mutations limit IFN b production
and enhance virus yield in the mouse lung
We have demonstrated that the majority of NS1 mutations
selected upon mouse adaptation increased virulence in CD-1 mice.
To assess the effect of MA NS1 mutations on IFN-b production,
IFN b levels were determined for infected mouse-lung extracts. We
infected groups of 3–6 mice intranasally with rHK-wt and rHK
NS mutants (1610
5 PFU dose) and then measured IFN-b
concentration in the lung extracts at both 1 and 3 days post-
infection using ELISA with subtraction of values from mock PBS
infected lungs. rHK-wt induced an average of 200 pg/g IFN-b in
the mouse lung 1 day following infection and all of the NS1
mutants induced significantly less IFN-b except mutants D2N
{
and M106I+L98S (Fig. 4, upper left panel). NS1 mutant D2N
{
was the sole mutant to induce significantly more lung IFN-b
production than rHK at 1 dpi (p,0.01). Notably, numerous NS1
mutants restricted the amount of IFN-b produced to below the
limit of detection 1 dpi (V23A, L98S, M106V, M106V+M124I,
V180A
{, V226I, and R227K
{)( p ,0.0001) (Fig. 4, upper left
panel). IFN-b levels in lungs collected 3 days pi were significantly
higher than rHK-wt for NS1 mutants D2N
{, L98S, M106I+L98S,
and V180A
{ (p,0.01, p,0.0001, p,0.0001, p,0.01, respective-
ly). However the amount of IFN-b produced was below the limit of
detection for five NS1 mutants at 3 dpi, mutants V23A,
M106V+M124I, D125G, V226I, and R227K
{.
Figure 3. Mouse adapted NS1 mutations increase pathology and virus spread in the mouse lung. Groups of 4 CD-1 mice were infected
with 1610
5 PFU dose of selected rHK NS mutant or rHK-wt viruses and two sets of lungs were collected at both 2 and 6 dpi. IF: Virus was detected by
immunofluorescence; frozen lung sections were stained with anti-HK primary antibody, Cy3- conjugated secondary antibody (red), and nuclei were
stained with Hoeschst (blue). Images were taken using a 206objective lens. White arrows indicate foci of staining at 6 dpi. H&E: Lung pathology was
assessed by H&E staining. Images were taken using a 106objective lens.
doi:10.1371/journal.pone.0031839.g003
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replication, we also determined the viral yield of each lung
sample used to determine IFN-b concentration. The rHK-wt
virus grew to 1.2610
7 PFU/gram 1 day pi, and then decreased
to 4.3610
6 PFU/g at day 3 pi (Fig. 4, right panels). All mutants
except L98S, F103L, M106I, and M106V + M124I resulted in
enhanced yields at one or both time points. Enhanced lung viral
titre was maintained at both day 1 and day 3 pi for NS1 mutants
M106I + L98S and D125G. At day 1 pi, NS1 mutants D2N
{,
V23A, and D125G grew to titres that exceeded rHK-wt .10
fold (p,0.0001, p,0.01, p,0.0001, respectively) and NS1
mutants M106I+L98S and R227K
{ also significantly exceeded
rHK-wt titres (p,0.0001, p,0.01, respectively) (Fig. 4, upper
right panel). At day 3 pi, lung titres for NS1 mutants
M106I+L98S, M106V, D125G, V180A
{, and V226I were
significantly greater than rHK-wt (p,0.0001, p,0.0001,
p,0.05, p,0.01, p,0.0001, respectively) (Fig. 4, lower right
panel). Compared to rHK-wt titre, viral growth was significantly
attenuated for NS1 mutant M106V + M124I at both day 1 and
3p i ( p ,0.001), as well as NS1 mutant V23A at day 3 pi
(p,0.05) (Fig. 4, right panel).
The reduced production of IFN-b that was associated with
similar or significantly higher viral replication therefore indicated
that these mutations function to reduce IFN-b production. The
reduced replication seen for NS1 mutant M106V + M124I may
account for the reduction in IFN-b produced by these mutants,
however role of the M124I mutation in this combination is
unknown. We thus conclude that NS1 mutants selected upon
mouse adaptation, with the exception of mutant M106V + M124I,
are capable of reducing the amount of IFN-b produced in the
mouse lung while maintaining or enhancing the level of viral
replication.
Identification of NS1 mutations that affect CPSF30-F2F3
binding
The majority of MA NS1 mutations mapped within binding
domains for cellular binding partners involved in mRNA
translation (eIF4GI and PABPI), post transcriptional processing
Figure 4. Mouse-adapted NS1 mutations affect IFN-b production and viral yield in the mouse lung. Groups of 6–12 female CD-1 mice
were infected intranasally with 1610
5 PFU dose of rHK NS mutants or rHK-wt or mock-infected with PBS. Lungs were collected 1 and 3 days pi,
homogenized, and quantified for IFN b concentration using a commercial murine IFN b ELISA kit (left panel), and for viral titre by plaque assay on
MDCK cells (right panel) Data represent the means 6 SD (*p,0.05, **p,0.01, ***p,0.001, ****p,0.0001; two-tailed unequal variance student’s t-
test).
doi:10.1371/journal.pone.0031839.g004
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(Fig. 5a). Given that previous studies have identified a role for
NS1: CPSF30 interaction in interferon antagonism [18,34], but
that other reports have associated CPSF30 binding with general
inhibition of host gene expression but not as a requirement for
inhibition of IFN-b [16,47,48], we next determined whether any
of the NS1 mutations selected upon mouse adaptation affected
NS1 binding to the F2F3 domain of human CPSF30, which is
identical in sequence to the mouse CPSF F2F3 domain [5].
Previously we had shown that recombinant 6xHis-tagged NS1
proteins with MA mutations at positions 103, 106 and 180 but not
23 or HK-WT had lost the ability to bind CPSF [5]. We next
assessed CPSF binding of the untagged NS1 mutants listed in
Figure 1a as well as NS1 mutant L98S. Briefly, mutant and HK-wt
NS gene segments as well as FLAG-tagged CPSF-F2F3 (FLAG-
F2F3) fragment were expressed in vitro by coupled transcription
and translation in the presence of
35S-methionine and cysteine
with detection by autoradiography following SDS-PAGE (Fig. 5b).
In an anti-FLAG antibody pulldown assay conducted in triplicate,
35S-labeled HK-wt and mutant NS proteins were mixed with
FLAG-F2F3 and precipitated using anti-FLAG M2 antibody and
Protein G Dynabeads (Invitrogen). Bound proteins were separated
by SDS-PAGE and detected by autoradiography (Fig. 5c) and
quantified by phosphorscreen detection (Fig. 5d). To verify specific
binding to the anti-FLAG antibody, a control pull-down was
performed in the absence of F2F3-FLAG protein, which showed a
lack of non-specific binding for all NS1 mutants (Fig. S1).
The NS1 mutants D2N
{ and V226I bound F2F3-FLAG with
comparable affinity to HK-wt NS1, but NS1 mutants V23A and
R227K
{ demonstrated a 2-fold increase in binding affinity
(p,0.05 and p,0.01, two-tailed student’s t-test). However, the
majority of NS1 mutants either partially or fully suppressed NS1-
F2F3 binding. NS1 mutants L98S and F103L bound at detectable
but significantly decreased levels than HK-wt NS1 (p,0.0001,
p,0.00001) (Fig. 5d). NS1 mutants M106I, M106I + L98S,
M106V, M106V + M124I, D125G, and V180A
{ demonstrated
undetectable binding to F2F3 in any of the three independently
conducted anti-FLAG F2F3 pulldowns (p,0.00001, Fig. 5d). The
data indicate that altered NS1:CPSF30-F2F3 binding affinity is a
common property for NS1 mutations selected upon mouse
adaptation, where two mutants demonstrated enhanced affinity
and the majority demonstrated a marked decrease in binding
affinity. These results show a lack of correlation between IFN-b
induction and CPSF binding.
Mouse-adapted NS1 mutations enhance viral growth in
vitro
To assess whether the adaptive properties associated with MA
NS1 mutants in vivo also correlated with an in vitro phenotype, we
determined the effect of MA NS1 mutations on viral growth in M1
cells, a mouse kidney epithelium cell line with intact IFN
production and response pathways [7]. Confluent monolayers
were infected with rHK-wt or rHK NS mutants at a low
multiplicity of infection (MOI=0.02) and viral titres were
quantified at 12, 24, 48, and 72 hours post infection (hpi). NS1
mutants D2N
{, V23A, L98S, M106I, M106I+L98S, F103L,
M106V + M124I, and D125G all significantly enhanced viral
yield throughout the course of infection compared to rHK-wt
(p,0.05 by two–tailed, paired, t test) (Fig. 6, left panel). The NS1
double mutant M106I + L98S induced the highest level of virus
growth; where at both 48 and 72 hpi the mutant grew to .100
fold higher titre than rHK-wt (p,0.0001 and p,0.001,
respectively, by two-tailed single sample t-test). NS1 mutants
M106V and R227K
{ significantly enhanced viral growth at early
times (12–24 hpi) compared to rHK-wt (p,0.01 and p,0.05,
respectively; two–tailed paired t-test), however their yields were
similar to rHK-wt at 72 hpi (Fig. 6, left panel). Mutations V180A
{
and V226I resulted in viral growth curves that were not
significantly different from rHK-wt (Fig. 6, left panel). All assayed
recombinants reached maximum virus yield at 72 hpi; this titre
was significantly increased for NS1 mutants D2N
{, V23A, L98S,
M106I+L98S, M106V + M124I, and D125G compared to rHK-
wt (p,0.05 by single sample t-test); however, the contributions of
the NS1 mutations in enhancing viral fitness is unknown for the
NS1 D2N
{ and R227K
{ mutants that also possess NEP mutations.
These results indicate that the majority of NS1 mutations (10 of
12; except mutants V180A
{ and V226I) selected upon HK-wt
virus passage in the mouse were adaptive in vitro, and increased
viral replicative fitness by up to 100 fold in mouse cells (Fig. 6, left
panel).
Mouse-adapted NS1 mutations increase viral growth in
IFN-b primed cells in vitro
Given that the NS1 protein is an interferon antagonist, we next
asked whether NS1 mutations selected upon mouse adaptation
affected resistance to interferon beta (IFN-b) pre-treatment upon in
vitro infection. We assayed viral growth in M1 cells as per the
previous protocol, however prior to infection the cells were primed
with 1000 U/mL recombinant mouse IFN-b for 24 h to induce an
antiviral state. rHK-wt viral yield was reduced by 16 fold by IFN-b
pre-treatment at 72 hpi, where viral yield reached a maxi-
mum of 2.3610
2 PFU/mL in IFN-b primed cells relative to
3.8610
3 PFU/mL yield in untreated cells (Fig. 6). NS1 mutants
D2N
{, L98S, M106I + L98S, M106V + M124I, and D125G all
significantly enhanced viral growth throughout the course of
infection in IFN-b primed cells when compared to rHK-wt
(p,0.001, p,0.01, p,0.01, p,0.05, p,0.001, respectively; two-
tailed paired t-test) (Fig. 6, right panel). Viral replication in IFN-b
primed cells was enhanced at early times in infection (12–24 hpi)
for NS1 mutants V23A, F103L, M106I, M106V, and R227K
{
compared to rHK-wt (p,0.01, by two-tailed, paired t-test). The
three NS1 mutants that produced the greatest viral yield in IFN-b
primed cells, M106I + L98S, M106V + M124I, and D125G,
exceeded rHK-wt maximum yield obtained at 72 hpi by 100, 78,
and 12 fold, respectively. These data indicate that the majority of
NS1 mutants selected upon mouse adaptation (10 of 12; all except
mutants V180A
{ and V226I) enhanced viral growth in both naive
and IFN-b primed mouse cells in vitro, consistent with a role for
IFN antagonism in enhanced growth in vitro.
Mouse-adapted NS1 mutations enhance HK virus mRNA
transcription in vitro
Since the majority of the NS1 mutants increased replication of
the HK virus in mouse cells in vitro, we next determined whether
this enhanced replicative fitness was due to increased viral mRNA
production. Confluent monolayers of M1 cells were infected in
triplicate with rHK-wt or rHK NS mutants (MOI=2) and total
RNA was extracted from the cells at 8 hpi for real-time
quantitative RT-PCR analysis of NS1, NP (a representative early
viral transcript), and M1 (a representative late viral transcript).
Figure 7 shows the average production of mRNA normalized to
the HK-wt yield 6 standard deviation for each of the NS1, NP,
and M1 genes. Upon statistical analysis pairing the groups of 3
genes, the relative mRNA abundance of the three viral transcripts
tested was significantly higher than rHK-wt for all NS1 mutants
(p,0.01, two-tailed paired t-test) with the exception of mutants
V180A
{ and V226I (Fig. 7). The greatest increases in mRNA
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31839Figure 5. Mouse-adapted NS1 mutants affect binding affinity to CPSF30-F2F3. (A) Map of NS1 protein indicating the location of NS1
mutations selected upon adaption of A/Hong Kong/1/1968 (H3N2) to the mouse, as depicted by black arrows. NS1 binding domains are depicted
within and below the protein diagram. (B) NS1 proteins (wt or mutant) as well as CPSF30-F2F3-FLAG were expressed by in vitro coupled transcription
and translation of expression plasmids or empty vector in the presence of
35S labeled methionine and cysteine and expression was evaluated by
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{, M106I + L98S, and
D125G mutants (.10 fold). All assayed viral mRNAs were shown
to be significantly upregulated for NS1 mutants D2N
{, L98S,
F103L, M106I, M106I + L98S, M106V, and D125G (Fig. 7,
p,0.05- p,0.000001, student’s t-test). Several NS1 mutants also
affected the ratio of NS1, NP and M1 mRNA transcript
Figure 6. Mouse-adapted NS1 mutations enhance virus growth in untreated and in IFN-b primed mouse cells in vitro. Mouse M1 cells
were untreated (left panel) or pre-treated with mouse IFN-b (1000 U/mL) for 24 hours (right panel), then infected in triplicate at an MOI of 0.02 with
rHK NS mutants or rHK-wt virus, and supernatant collected 12, 24, 48, and 72 hpi was quantified for viral titre by plaque assay on MDCK cells.
Graphical analysis of data was broken into three mutant sets, with rHK-wt included in each, due to the number of mutants surveyed. Data represent
the means 6 SD (*p,0.05, **p,0.01, ***p,0.001; two-tailed student’s paired t-test for 12–72 hpi, indicated by horizontal bracket above time range).
doi:10.1371/journal.pone.0031839.g006
autoradiography. Radiolabeled mutant or HK-wt NS1 proteins or empty vector were mixed with radiolabeled CPSF30-F2F3-FLAG and subject to pull-
down using a-FLAG M2 antibody bound to Protein G Dynabeads then SDS-PAGE electrophoresis and autoradiography. (C) Representative pull-down
of 3 independent replicates. (D) Pull-down SDS gels were subject to PhosphorScreen signal amplification, then band intensity quantification using GE
Imagequant software. Data represent the means 6 SD (*p,0.05, **p,0.01, *** p,0.001, ****p,0.0001; *****p,0.00001; two-tailed student’s t-test)
for relative NS1 binding.
doi:10.1371/journal.pone.0031839.g005
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NS1 mRNA for NS1 mutant L98S (p,0.05), and levels of M1 and
NP mRNA were both significantly higher than NS1 mRNA for
NS1 mutants M106V + M124I and D125G (p,0.05, NP.NS1
mRNA; p,0.01, M1.NS1 mRNA) (Fig. 7).
To further support the findings of NS1-mediated increased
RNA synthesis, we next performed a luciferase mini-genome assay
to determine the effect of mutant NS gene segments on viral RNA
polymerase activity. RNA polymerase activity was measured in
HEK 293-T cells by detecting luciferase activity expressed from an
influenza firefly luciferase mini-genome plasmid expressed via
human RNA polymerase I transcription of luciferase flanked by
the NP gene non-coding regions [5] in the presence of HK-wt
PB2, PB1, PA, NP and various HK-wt or mutant NS genome
segments, as detailed in methods. Virus-dependent transcription of
firefly luciferase was standardized to the level of renilla luciferase
expressed via the constitutive SV40 promoter of the PRL-SV40
plasmid. When comparing polymerase activity in the presence of
HK-wt NS and NS mutants, NS1 mutants F103L, M106I,
M106V, D125G, and V180A
{ all increased polymerase activity by
.2.5 fold (p,0.01, student’s t test) (Fig. 8). The NS1 mutants with
the highest increases in viral polymerase activity, M106V+M124I
and M106I+L98S, both increased activity .4.5 fold compared to
rHK-wt NS (p,0.01, student’s t-test) (Fig. 8), which indicated
enhanced activity due to the second mutation in both instances.
Renilla expression via the host RNA polymerase II was not
significantly different from HK-wt for any of the NS gene mutants
(Fig. 8). Thus all NS1 mutants that demonstrated increased viral
polymerase activity in the RNA polymerase minigenome assay
also demonstrated increased viral mRNA production in infected
cells (Fig. 7) with the exception of NS1 mutant V180A
{. The
increased transcription seen in infected M1 cells for the D2N
{,
V23A, and R227K
{ was not associated with increased RNA
polymerase activity and suggests an indirect mechanism of action
on RNA synthesis. The V226I mutant did not demonstrate
increased RNA synthesis by either assay indicating that the
increased replication in vivo may be independent of enhanced RNA
synthesis.
Expression of the HK-wt NS gene segment was also shown to
decrease viral polymerase activity when compared to the empty
vector control (p,0.01) (Fig. 8), which suggested a negative
regulatory effect due to the NS1 and/or NS2/NEP genes
expressed from the NS construct. By using pLLB vector plasmids
that express the NS gene segment, versus NS1 or NS2/NEP genes
alone (see methods), we found that expression of the NS gene
segment inhibited viral polymerase activity due to NS1 and NS2/
NEP gene expression (Fig. S2). Moreover, expression of NS1 alone
was shown to significantly reduce renilla luciferase activity,
however upon co-expression with NEP in the NS gene segment,
renilla luciferase activity was similar to the vector control (Fig. S2).
Further analysis is required to determine the mechanism of
polymerase activity regulation by the NS1 and NS2/NEP
proteins.
This data shows NS1 mutants selected upon mouse adaptation
increase viral gene expression at the level of transcription both in
the luciferase mini-genome assay and in infected mouse cells. In
addition some NS1 mutants also differentially affect transcriptional
regulation.
Mouse-adapted NS1 mutations enhance HK virus protein
synthesis in vitro, in untreated and IFN-b primed M1 cells
Given that the NS1 protein enhances viral protein synthesis as
well as antagonizes IFN-mediated inhibition of virus replication,
we hypothesized that the increase in viral growth of the NS1
mutants in IFN-b primed mouse cells compared to rHK-wt virus
may be due to increased IFN-resistant viral protein synthesis. To
Figure 7. Mouse-adapted NS1 mutations enhance viral mRNA production in mouse cells in vitro. Mouse M1 cells were infected in
triplicate at an MOI of 2 with rHK NS mutants or rHK-wt virus, and total RNA isolated at 8 hpi was reverse transcribed using primers specific for viral
mRNA. Real-time PCR (qPCR) was performed to quantify NP, M1 and NS1 viral mRNA levels. Results were normalized by b-actin levels, and presented
as values relative to rHK-wt mRNA levels. Data represent the means 6 SD (two-tailed student’s paired t-test) for NP, NS1 and M1 mRNA relative levels
(indicated by bracket) or two-tailed student’s t-test for individual mRNA relative values (i p,0.05; ii p,0.01; iii p,0.001; iv p,0.0001; v p,0.00001).
doi:10.1371/journal.pone.0031839.g007
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protein synthesis, and whether these mutations influenced
resistance of viral protein synthesis to the IFN-b-mediated anti-
viral response, we evaluated the level of M1 and NS1 viral protein
synthesis by pulse labelling with
35S-labeled cysteine and
methionine residues during the course of infection in M1 cells
(MOI=2), both in untreated and in IFN-b primed cells that were
treated with 200 U/mL mouse IFN-b for 24 hours prior to
infection.
Although rHK-wt produced detectable M1 and NS1 proteins in
untreated cells beginning at 8 hpi, and at a reduced level in IFN-b
primed cells, viral protein bands were prominent for the double
mutant M106I + L98S starting at 4 hpi in both untreated and IFN-
b primed cells (Fig. 9a). Similar to the double mutant, the NS1
mutant L98S produced detectable viral proteins starting at 4 hpi
(data not shown). Given that the remaining NS1 mutants did not
demonstrate increased viral protein synthesis relative to rHK-wt
before 8 hpi (data not shown), quantification of M1 and NS1
protein bands was performed for 8 hpi samples from both cell
conditions as mean values 6 standard error for duplicate
experiments (Fig. 9a–d). With respect to HK-wt and NS1 mutant
infection, IFN-b pre-treatment was shown to suppress viral protein
synthesis compared to infection in untreated cells (Fig. 9a–b).
Although there was a trend to increased synthesis for one or both of
the NS1 and M1 proteins for all the NS1 mutants except mutants
V180A
{ and V226I relative to rHK-wt at 8phi in untreated cells,
significantly increased levels of viral protein were seen for NS1
mutants V23A (M1 protein, p,0.05), L98S (M1 protein, p,0.05;
NS1 protein, p,0.01), M106I+L98S (M1 and NS1 proteins,
p,0.05), M106V+M124I (M1 protein, p,0.01), D125G (M1
protein, p,0.001), and R227K
{ (NS1 protein, p,0.05) (Fig. 9a–c).
NS1 mutants L98S and M106I+L98S both produced the most viral
protein; compared to rHK-wt, L98S produced .2.5 fold more M1
and NS1 protein, and mutant M106I+L98S produced .4 fold
more M1 and NS1 protein (Fig. 9c).
In IFN-b primed cells, both NS1 mutants L98S and M106I +
L98S produced the highest levels of viral protein compared to
rHK-wt; NS1 protein levels were .2.5 fold higher for NS1 mutant
L98S (p,0.01), and both M1 and NS1 levels were .8 fold higher
than rHK-wt for mutant M106I + L98S (p,0.05) (Fig. 9d). The
remaining mutants, with the exception of NS1 mutants V23A and
V226I, demonstrated a trend of increased viral protein synthesis
that was significantly greater than rHK-wt for NS1 mutants F103L
(M1 protein, p,0.05), M106V (M1 protein, p,0.01) and V180A
(M1 protein, p,0.01; NS1 protein, p,0.05) (Fig. 9d).
The ratio of M1 protein production to NS1 protein production
was significantly affected for NS1 mutant M106V+M124I.
Whereas rHK-wt produced equal band intensities for M1 and
NS1 proteins at 8 hpi in untreated cells, NS1 mutant M106V +
M124I produced significantly more M1 protein than NS1 protein
(p,0.01) (Fig. 9b–c). NS1 mutants D2N
{, D125G, and R227K
{
also exhibited a trend of increased M1 protein relative to NS1
protein although the difference was not statistically significant
(Fig. 9b–c). To determine whether the observed differences in M1
to NS1 protein ratio was due to decreased NS1 protein stability,
we performed a radioactive pulse-chase experiment. Briefly, M1
cells were infected with rHK-wt, and NS1 mutants M106V +
M124I, D2N
{, D125G, and R227K
{ as per previous experiment.
At 8 hpi the cells were pulsed with
35S-labeled cysteine and
methionine, then at 9 hpi, the cells were either collected (pulse
samples) or were chased with complete MEM for 1 or 3 hours
(n=3) (Fig. 10a). The data demonstrate that compared to rHK-wt
NS1 and M1 protein stability, the NS1 mutants tested did not
affect the stability for these proteins, measured as the ratio of M1
to NS1 protein levels in each condition (Fig. 10b). An additional
protein band of 20 kDa was detected with NS1 antibody in
D125G infected cells and is the subject of further investigation
(Selman, Forbes, Dankar, and Brown, in preparation). Taken
together, these observations indicated that several NS1 mutations
altered the temporal regulation of viral protein production in a
gene-dependent manner (Fig. 9b–c, Fig. 10). The observation that
Figure 8. RNA polymerase mini-genome assay. Viral RNA
polymerase activity was measured in HEK 293-T cells expressing mutant
or HK-wt NS genes as well as HK-wt PB2, PB1, PA, NP, and firefly
luciferase driven by the NP promoter. (A) Relative polymerase activity
was calculated as the ratio of firefly luciferase to renilla luciferase (under
SV40 promoter control) luminescence and presented as means 6 SD for
three experiments (**p,0.01, student’s t test). (B) NS mutants do not
affect host gene expression. Renilla luciferace activity in cells
transfected with HK RNP is not affected by NS mutant expression
(p.0.05, student’s t-test) compared to HK wt NS expression.
doi:10.1371/journal.pone.0031839.g008
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relative increases in protein synthesis suggests that restrictions in
protein synthesis are limiting gene expression in the mouse system.
The increased viral mRNA levels, viral protein synthesis and
IFN-b resistance of viral protein synthesis were consistent with the
enhanced rates and levels of viral replication in mouse M1 cells
and also demonstrated an increased resistance to type I IFN
antiviral mechanisms (Fig. 6, 7, 8, 9).
Discussion
Although the NS1 protein has multiple binding partners and
functions that promote viral replication, including antagonism of
the IFN response, it is not clear which functions are altered or
enhanced in virulent variants. We employed mouse adaptation as
an unbiased approach to identify adaptive mutations in the NS1
gene, an approach that has identified adaptive mutations in the
polymerase and receptor binding protein that have been
confirmed to increase replication and virulence [5,7,45,46].
Consistent with the multiple roles of the IAV NS1 protein in
supporting virus replication, we demonstrated that the selection of
A/Hong Kong/1/1968 virulent variants in the mouse led to
identification of key NS1 mutations responsible for adaptation and
virulence in a novel host. By generating recombinant HK viruses
differing in their NS gene segment we demonstrated that
individual and multiple MA NS1 mutations increased viral
replication, viral gene expression, virulence in the mouse, and
antagonism to IFN-b, both by limiting the amount of the antiviral
Figure 9. Mouse-adapted NS1 mutations enhance virus protein synthesis in untreated and IFN-b primed mouse cells in vitro. M1 cells
were left untreated or were pre-treated with 200 U/mL murine IFN-b for 24 hours, then infected with rHK NS MA or HK-wt virus at an MOI of 2. At 2, 4, 6,
and8 hpi thecellswere pulsedwith
35S for onehour then lysatewas collectedinSDSbuffer. Autoradiography ofcollectedsamples areshownfor(A)full
timecoursesofHK-wtandrHKNSM106I+L98S and(B)8 hourtimepoints ofallNSmutants.(+) and(2) symbolsindicatewhether cellswerepre-treated
with IFN-b. NP, M1 and NS1 protein positions are indicated, and were verified by western blot (data not shown). Data shown are representative of two
independent experiments, which were each subject to densitometry analysis. Data represent the means 6 SE (*p,0.05, **p,0.01, *** p,0.001; two-
tailed student’s t-test) for NS1 and M1 protein band density relative to rHK-wt in untreated cells (C) and in IFN-b primed cells (D).
doi:10.1371/journal.pone.0031839.g009
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virus replication (summarized in Table 1).
Whereas very few NS1 mutations have been identified in
genomic analyses of other MA variants, we have employed high
dosages and increased the number of passages, which resulted in
virulent variants with mutations in the NS1 gene [5]. Here we
show that all mutant NS1 genes increased viral replication in
mouse cells and/or mouse lungs indicating that they have acquired
adaptive properties. Increased replicative fitness in untreated
mouse cells was seen at the level or rate of virus growth as well as
virus gene expression (at both the mRNA and/or protein levels),
for all NS1 mutants except V180A
{ and V226I. (Fig. 6, 7, 8, 9,
Figure 10. NS1 mutants with altered M1: NS1 protein production ratio do not demonstrate altered viral protein half lives. M1 cells
were infected with specified rHK NS1 mutants or HK-wt virus at an MOI of 2. At 8 hpi the cells were pulsed with
35S for one hour. For pulse samples,
the lysate was then collected in SDS buffer. For chase samples, the pulse medium was replaced with serum-free MEM then cell lysate was collected 1
or 3 hours later (n=3). (A) Autoradiography of collected samples, indicating bands corresponding to M1 or NS1 protein, as verified by Western blot,
(B) protein bands were quantified by PhosphorScreen signal amplification, then band intensity quantification using GE Imagequant software. Data
represent the means 6 SD of the ratio of M1 to NS1 protein levels. Statistical analysis was performed, however no virus induced a statistically
significant (p,0.05, student’s t test) difference in the ratio of M1:NS1 from pulse to chase.
doi:10.1371/journal.pone.0031839.g010
Table 1. Adaptive properties of rHK viruses expressing mouse-adapted NS mutations
5.
HK-wt D2N
{ V23A L98S F103L M106I M106I + L98S M106V M106V + M124I D125G V180A
{ V226I R227K
{
% mortality 08 3 02 0 02 0 4 0 2 00 2 0 2 000
weight loss
1 1 3.4 1.9 1.9 2.1 3.8 3.3 3.1 2.7 2.9 2.0 1.0 1.7
Lung IFN-b
2 1 1.4 0 0 0.12 0.54 1.0 0 0 0.03 0 0 0
Lung titre 1 dpi 1 12.0 16.4 1.0 1.0 1.3 7.6 1.1 0.02 13.4 0.92 0.74 2.35
Lung titre 3 dpi 1 0.75 0.38 1.5 0.57 1.1 2.3 3.2 0.03 4.1 2.2 5.3 0.79
CPSF binding 1 0.87 2.1 0.08 0.02 0 0 0 0 0 0 1.1 2.2
Yield in vitro
3 1 12.5 3.9 10.7 2.8 1.6 121 1.3 53.9 20.5 1.0 0.74 1.2
Yield +IFN
2 1 8.1 6.9 3.4 1.6 1.4 100 1.2 78.4 12.0 0.50 0.23 0.90
viral mRNA
4 1 13 1.5 11.4 5.0 5.5 18.6 1.8 5.6 13.4 1.2 1.0 3.4
RNA polymerase 1 0.7 0.5 nd 2.7 3.2 5.2 3.3 4.7 3.2 2.8 0.5 0.6
viral protein
3 1 1.9 1.4 2.6 2.0 1.4 4.3 1.1 1.0 2.0 1.1 0.6 1.7
viral protein
+IFN
3
1 1.6 1.2 3.1 2.0 1.6 8.4 1.6 1.1 2.1 1.4 1.1 1.6
1Assessed at respective dpi with maximum weight loss for each respective virus.
2Fold change values of lung IFN-b levels 1 day pi.
3Relative maximum titre obtained 72 hpi (Fig. 6).
4Fold change of overall mRNA expression (NP + M1 + NS1; Fig. 7) or overall viral protein expression (M1 + NS1; Fig. 9c–d), respectively.
5All fold values are relative to rHK-wt phenotype; where 0 represents below the limit of detection by the respective assay, with the excetion of % mortality, which is
expressed as values independent to rHK-wt. (nd, not determined).
doi:10.1371/journal.pone.0031839.t001
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exception of V226I exhibited enhanced yield and/or replication
kinetics (Fig. 6, Table 1). Moreover, viral protein synthesis in cells
primed with IFN-b was enhanced for 5 of 12 NS1 mutants (L98S,
F103L, M106I+L98S, M106V, and V180A
{) (Fig. 9d). Analysis of
the role of mouse-adapted NS1 mutations in the mouse lung in vivo
(summarized in Table 1) demonstrated increased virulence and
disease severity for most mutations, where all NS1 mutants with
the exception of V226I and R227K
{ significantly increased body
weight loss compared to rHK-wt from days 1–6 pi (Fig. 2b,
Table 1). Moreover, the amount of IFN-b produced in the mouse
lung was significantly less than rHK-wt for most NS1 mutants, and
of these mutants, the majority induced greater viral yield relative
to rHK-wt levels (Fig. 4, Table 1), which suggests a model for
selection of NS1 mutations upon host adaptation, where mutations
that enhance IFN-b antagonism demonstrate increased viral yield
(Fig. 11). Lower IFN-b induction in the mouse lung upon
intranasal infection was consistent with the observation of a
prototype mouse-adapted strain; A/PR/8/34 (H1N1), that
induced low levels of IFN-b in the lung (21.768.7 pg/g) relative
to the A/Hong Kong/1/1968 (H3N2) human clinical isolate that
induced 668.56353.5 pg/g upon intranasal inoculation of
1610
5 PFU dose in BALB/c mice (data not shown). However,
in the case of the two NS1 mutants that induced the greatest
mortality, D2N
{ and M106I + L98S, viral yield in the lung was 12
and 8 fold greater than rHK-wt (1 dpi), while the corresponding
level of IFN-b concentration was significantly increased but only
by 50% (p,0.01) or was similar to rHK-wt, respectively (Fig. 4,
Table 1). Both D2N
{ and M106I + L98S NS1 mutants induced
greater pathology in the lung and virus spread in the lung
compared to rHK-wt (Fig. 3). Taken together, these findings
identify multiple adaptive paths employed by NS1 mutations
selected upon human IAV passage in the mouse. We speculate
that NS1 mutations that confer decreased IFN-b induction in the
mouse lung may in some cases allow replication to higher titres
before inhibitory levels of IFN are reached, ultimately resulting in
greater spread and infection in the lung and correspondingly,
increased disease severity and mortality (as seen for the majority of
Figure 11. Model of adaptation of human HK-wt influenza virus to the mouse lung to enhance IFN-b antagonism. Mouse adaptation
involves the selection of NS1 mutants with enhanced IFN-b antagonism, so that upon infection of mouse lung cells in vivo the mutant NS1 gene
reduces IFN-b gene (in yellow) activation in the nucleus and thus IFN-b protein (green) production and release. Therefore adaptive mutations prevent
the IFN-b induction of an antiviral state that is mediated through binding of to the IFN-a/b receptor (IFNAR). This model proposes that reduced IFN-b
production leads to a reduction in the antiviral state and greater virus yield.
doi:10.1371/journal.pone.0031839.g011
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the first demonstration of adaptive mutations in the NS1 gene that
result in greater antagonism of IFN induction, and one of the few
reports that describe increased antagonism of the IFN-induced
antiviral response and virulence [9]. Adaptive mutations in the
NS1 gene that lead to decreased IFN production could block IFN
induction at the level of RIG-1-mediated viral RNA sensing where
NS1 amino acids at residues 96 and 97 have been associated with
this mechanism to interfere with IFN induction [14], especially for
adaptive NS1 mutations proximal to this region (Fig. 5a).
Alternatively, there is a possibility that reduced IFN-mediated
signaling and activation of IFN-inducible effector genes (including
the autocrine amplification of type I IFN production) could also be
affected by adaptive NS1 mutations [15]. Future research on the
effect of NS1 mutants on these antiviral signaling pathways will
identify the mechanism(s) employed to enhance IFN antagonism.
NS1 suppression of IFN-b induction is independent of
ability to bind CPSF30-F2F3
A primary function of NS1 protein is to inhibit activation of IFN
mRNA transcription by interfering with RIG-I-mediated detection
of viral RNA. However, numerous studies have shown that the
ability of NS1 to inhibit general host gene expression is dependent
upon the ability to bind the F2F3 domain of the post-
transcriptional processing factor CPSF30, and that this interaction
leads to the suppression of host mRNA processing, including type I
IFN mRNA [17,18,34]. Some studies have shown that the loss of
CPSF binding through in vitro mutagenesis is associated with
increased IFN induction and attenuated growth for A/Udorn/1/
1972 (H3N2) [18] or its reassortant possessing the 1997 H5N1
NS1 gene [34]. However, other studies of natural variants that do
not bind CPSF show that these viruses (mouse-adapted A/PR/8/
34 (H1N1) [47] and pandemic 2009 H1N1 isolates [48]) maintain
the ability to block IFN-b production but lose the ability to block
general host gene expression; where restoration of CPSF30
binding (that required the mutagenesis of 2 or 3 aa, respectively)
resulted in slightly increased or reduced virulence, respectively.
Consistent with these data we observed that NS1 mutations
selected on mouse adaptation in many cases reduced or blocked
CPSF30-F2F3 binding but increased replication, RNA polymerase
activity, virulence and IFN antagonism. Specifically, NS1
mutations at sites L98S and F103L significantly decreased binding
to CPSF30-F2F3 and mutations at aa site 106 (M106I, M106I +
L98S, M106V, M106V+M124I) as well as NS1 mutants D125G
and V180A
{ abolished binding to CPSF30-F2F3 (Fig. 5c–d).
Moreover, all NS1 mutants with suppressed CPSF30-F2F3
binding with the exception of mutant M106I + L98S were able
to reduce the amount of IFN-b produced in vivo 1 dpi to levels #
rHK-wt, while attaining viral yields that were $ rHK-wt in the
mouse lung demonstrating a lack of correlation between CPSF-
binding and IFN-b synthesis (Fig. 4, Fig. 5). Our data are
consistent with the recent study of Steidle et al. (2010), where a
mutant A/PR/8/34 (H1N1) virus with restored binding to
CPSF30 due to S103F+I106M substitutions was rendered
deficient in binding CPSF30 upon further amino acid substitution
(G184R) but still remained capable of inhibiting IFN production
[47]. Because host mRNA transcripts are required as primers for
IAV transcription [49] and many host genes are required for viral
replication [50], increased general host gene expression by
reduced NS1:CPSF30 binding may be adaptive in a new host
environment where virus replication is deficient. In this regard we
have observed a reciprocal relationship between CPSF binding
and RNA polymerase activity where viruses that have lost CPSF
binding demonstrated increased RNA polymerase activity (Fig. 5
and 8, Table 1). Further research on the effect of MA NS1
mutants on these properties is expected to identify alternative
mechanism of IFN antagonism.
MA NS1 mutations enhance viral gene expression
All NS1 mutants except V180A
{ and V226I were found to
increase viral mRNA synthesis in infected cells, and 7 of 11 MA
NS gene segments were found to increase viral polymerase activity
in HEK 293-T cells, which in several cases correlated with
increased viral protein synthesis compared to rHK-wt (Fig. 7, 8, 9,
Table 1). This indicates that NS1 mutations selected upon mouse
adaptation increase viral gene expression indicating a functional
interaction between the NS1 gene and polymerase activity due to
direct or indirect interactions with viral polymerase components.
This hypothesis is supported by numerous studies that have linked
NS1 action with the ability of influenza virus to synthesis viral
RNA or associate with components of the polymerase complex
[23,29–34]. Increased viral protein synthesis was also shown for
HK NS1 F103L and M106I mutations when expressed on the A/
PR/8/34 (H1N1) backbone [7] and given the location of these
and D2N
{, V23A, L98S and M106V MA NS1 mutations within
binding domains for cellular factors involved in translation
(eIF4GI, PABPI; Fig. 5a), we cannot rule out the possibility that
enhanced interaction with these factors may also contribute to
increased levels of viral protein synthesis.
In addition to increased yields of viral mRNA and protein, we
observed differential regulation of M1 and NS1 protein synthesis
relative to rHK-wt levels. NS1 mutants D2N
{ and D125G induced
lower levels of NS1 protein relative to M1 protein, that was also
demonstrated at the level of mRNA synthesis. Pulse chase protein
labeling demonstrated this phenotype was not due to alteration of
NS1 protein stability (Fig. 10). Loss of temporal regulation of
transcription has been shown for alanine mutations at position
123+124 in NS1 [23]. Further research on the effect of MA NS1
mutants that increase viral protein synthesis (Fig. 9) on binding to
cellular translation factors is required to determine the mechanism
of viral protein synthesis enhancement.
MA NS mutations which induce mutations in the nuclear
export protein
Several NS1 mutations reside in the overlapping reading frame
for the nuclear export protein (NEP), also known as non-structural
protein 2 (NS2), a spliced gene product of the mRNA expressed
from gene segment 8. The NEP is known to function in nuclear
export of viral ribonucleoproteins (vRNPs) in association with the
matrix protein (M1) [51–54]. The NEP protein has also been
linked to regulation of viral transcription and replication of the
viral genome in a mechanism that is independent of vRNP nuclear
export [55]. Of the MA viruses with NS1 mutations, 4 contained
NEP mutations (Fig. 1a). The mouse-adapted variants MA62 and
MA63 possessed the NS1 mutation V180A, which concurrently
induced the NEP mutation S23P. The NS gene segment of MA93
(NS1 D2N) that induced the highest level of virulence when
expressed as a rHK NS mutant (Fig. 2), contained two NEP
mutations, D2N and E108K. Since both the NS1 and NEP
proteins have the first 10 amino-terminal aa in common, it is
possible that NS1 and NEP mutations within this region involve a
common mechanism of action. MA112 (R227K) also contained
NEP mutation G70S due to the same nucleotide substitution in the
overlapping NEP gene. Currently we are unable to separate the
effects of these NEP mutations from their associated NS1
mutations when expressed as a recombinant NS mutant virus
due to the restrictions of independently mutating overlapping
codons. Future studies could employ a modified gene 8
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al. (2010), where the two NS1 and NEP genes could be
independently engineered to unlink the incorporation of NS1
and NEP mutations [56].
Mouse adapted NS1 mutations: Pattern of Selection
Adaptation of the human isolate A/Hong Kong/1/1968 to the
mouse resulted in strong selection for highly virulent mouse-
adapted variants, 18 of 39 which contained mutations in the NS1
gene [5]. Two incidences of convergence occurred between
separately evolved virus populations, where two independently
passaged virus populations both selected mutations at amino acid
location 106 (M106V, and M106I, respectively), and another two
independently passaged populations selected the D125G mutation
[5] which was also independently selected in the H3N2 mouse
adapted variant of A/Aichi/2/68 [44]. The adaptation of duck
H9N2 virus to quail has also been shown to select a mutation at
position 106 (M106T) [57] that further supports that this site is an
important modulator of NS1 gene function. We also obtained
mutations in adjacent amino acid positions, 124+125 and
226+227, suggesting that these are focal adaptive regions within
the NS1 gene. A pattern of sequential NS1 mutation was seen
where 3 of 3 variants in one passaged virus population possessed
mutation M106I and 2 of 3 possessed a second mutation, L98S
[5]. Both NS1 mutants M106I and L98S increased viral fitness
and virulence compared to rHK-wt and together demonstrated
synergy where the phenotype of the double mutant M106I+L98S
was significantly increased (Fig. 2, 3, 4, 6, 7, 8 and 9). This suggests
that double mutations in NS1 may have the greatest phenotype by
compensating or synergizing properties that enhance replication in
the new host. In another passaged population, the presence of the
NS1 mutation M106V in all 3 clones with the additional M124I
mutation in clone 3 [5] was associated with increased in vitro
phenotypes of the M106V+M124I mutant relative to the M106V
mutant, and was consistent with a sequential selection of
synergistic mutations.
Sequence comparisons with NS1 genes derived from highly
virulent IAV isolates identified numerous incidences of conver-
gence between such strains and our MA strains. A/Hong Kong/
156/1997(H5N1) is convergent with the MA NS1 mutations at
amino acid sites 23A, 103L, and 106I. The F103L and M106I
mutations have been demonstrated to confer increased virulence
in the A/Hong Kong/156/1997 NS1 gene when expressed on the
A/Puerto Rico/8/1934 (H1N1) and the A/Chicken/Beijing/1/
1995 (H9N2) NS1 gene expressed on the A/WSN/33 (H1N1)
mouse-adapted genetic backbone as recently shown by Dankar
et al. (2011) [7]. As mentioned earlier we have shown that the HK
NS1 V23A mutation enhanced virulence 6 fold [46]. The NS1
mutation D125G, which resides within the NS1 PKR binding
domain, was also selected upon adaptation of the human influenza
virus isolate A/Aichi/2/68(H3N2) to high virulence in the BALB/
c mouse [44], which suggests that NS1 interactions with PKR may
confer an adaptive advantage upon evolution in a new host. NS1
mutations 226I and 227K are also shared with the 1918 Spanish
influenza A/Brevig Mission/1/1918 (H1N1) NS1 gene [58],
which has been shown to contribute to virulence in infected
Macaques [59] and delay IFN induction in ferrets [60]. Although
the R227K and V226I mutations were shown to be adaptive in vivo
when expressed as single mutations (Fig. 4), neither induced
significant increases of morbidity in the mouse (Fig. 2), however it
is possible that these mutations contribute to the virulence of the
1918 pandemic in the context of the 1918 NS1 protein or other
1918 viral genes.
In summary, all mutant NS1 genes selected upon IAV passage
in the mouse were adaptive and increased replication that was in
most cases associated with increased virulence in the mouse.
Increased replication was associated with increased gene expres-
sion and IFN antagonism. Consistent with the role of NS1 in IAV
as a virulence factor we have identified NS1 mutations that control
adaptive properties associated with host adaptation and virulence.
Materials and Methods
Ethics Statement
All in vivo research was performed in accordance with the
guidelines of the Canadian Council on Animal Care (CCAC) as
outlined in Care and Use of Experimental Animals, Vol. 1., 2nd
Ed (1993), which are internationally recognized as ‘‘best practices’’
by the International Council for Laboratory Animal Science
(ICLAS). The animal study protocol was approved by the
University of Ottawa Animal Care Committee (Protocol
No. BMI-85). All efforts were made to minimize suffering, and
mice were humanely euthanized upon experimental endpoint
(when infection resulted in greater than 30% body weight loss
accompanied by respiratory distress).
Cells and viruses
MDCK (Madin-Darby canine kidney, Health Canada, Ottawa,
Canada) and M1 (Mouse kidney epithelium, ATCC) cells were
maintained in minimum essential medium (MEM), and 293T
(Human embryonic kidney, ATCC) cells were maintained in
Dulbecco’s minimal essential medium (DMEM) (Gibco, Invitro-
gen), both supplemented with L-glutamine (2 mM), Penicillin
(100 U/ml), Streptomycin (100 ug/ml) and fetal bovine serum
(FBS) (10%). All cells were incubated at 37uC in the presence of
5% CO2. The H3N2 human influenza isolate A/Hong Kong/1/
1968 (HK-wt) was obtained from the Laboratory Center for
Disease Control (Health Canada, Ottawa, Canada). Viruses were
plaque purified in MDCK cells and grown in the allantoic cavity
of 10-day-old SPF chicken embryos (Canadian Food Inspection
Agency, Ottawa).
Directed evolution of influenza A virus in the mouse lung
The generation of mouse-adapted (MA) variants after 20 or 21
passages (MA20 or MA21) in the CD-1 mouse lung was described
previously [42,5]. All MA21 viruses were designated as MA
(mouse passage population #)-(clone #) and referred to by their
indicated abbreviation (Fig. 1a).
Plasmid Construction
Genome segment 8 cDNA of A/Hong Kong/1/1968 was
inserted into the bi-directional pLLB vector by ligation-indepen-
dent cloning [61]. Each MA NS mutation was introduced into the
HK NS gene (Genbank accession no. CY033005) by PCR-based
site-directed mutagenesis. All of the plasmid constructs were
sequenced to ensure the absence of unwanted mutations. The
F2F3-FLAG pET17b plasmid under T7 promoter control was
constructed using homologous recombination. Briefly, pCAGGS-
CPSF30-F2F3-FLAG (obtained gratefully from L. Martinez-
Sobrido, Mt. Sinai School of Medicine) was cloned using primers
specific to CPSF-F2F3-FLAG with homologous ends to pET17b
sequence upstream of the T7 promoter. The F2F3-FLAG
construct was subject to homologous recombination with pET17b
using DH5a E.coli competent cells. Positive colonies were subject
to sequencing to verify proper insertion of construct. The CPSF30
F2F3 gene was of human origin, however the F2F3 portion of
CPSF30 is completely conserved in the mouse [5].
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Each MA-NS pLLB plasmid was incorporated into the parental
HK-wt genomic backbone (Genbank accession no. CY033001–
CY033008) derived from pLLB plasmids expressing gene
segments 1–7 of HK-wt to generate recombinant NS mutants.
Virus rescue was performed using an 8 plasmid system as
described previously [62,63]. Briefly, DNA and Lipofectamine
2000 (Invitrogen) were mixed in a 1 ug:2 uL ratio, incubated at
room temperature for 30 minutes and then used to transfect 90%
confluent 293-T cell monolayers in 6-well plates. Following
16 hour incubation, the cells were supplemented with Opti-
MEM (Gibco, Carlsbad, CA) containing 1 ug/mL TPCK trypsin
(Thermo Fisher Scientific, Waltham, USA). Two days later, the
supernatants were used to inoculate 10-day old SPF chicken
embryos for virus propagation. Virus rescue was assessed by
hemagglutination assay with chicken red blood cells (Canadian
Food Inspection Agency, Ottawa). To ensure absence of unwanted
mutations, viral RNA was extracted from 140 ul of stock allantoic
fluid from each recombinant virus using the QIAamp Viral RNA
Mini Kit (Qiagen, Mississauga, Ontario) before reverse transcrip-
tion and sequencing of each NS genome segment as previously
described [42]. Recombinant NS mutants with NEP mutations
(Fig. 1a) are indicated by an
{ throughout the text.
Mouse infections
All mouse infections in this study employed 19–21 gram female
CD-1 mice (Charles River Laboratories, Montreal, Quebec,
Canada).
Calculation of median lethal dose (MLD50)
Groups of 5–6 mice were infected intranasally under halothane
anaesthesia with 50 mL volumes of 10 fold serial dilutions in PBS
of viruses. Mortality and weight loss were monitored for 14 days.
MLD50 was calculated using the Karber-Spearman method [64].
Survival assays of recombinant HK NS mutants
Groups of 5–6 mice were infected intranasally under halothane
anaesthesia with 5610
6 PFU of the rHK NS mutants or rHK-wt,
with the exception of NS1 mutant M106V+M124I, where the
infection was performed at 2.5610
6 PFU dose due to insufficient
virus titre. Mortality and body weight loss were monitored for 14
days.
Viral growth and IFN-b production in the mouse lung
Groups of 6–12 mice were infected intranasally under halothane
anaesthesia with 1610
5 PFU of rHK NS mutants expressing NS1
mutations D2N
{, L98S, M106I or M106I+L98S, as well as the
rHK-wt virus in a 50 mL volume. At days 1 and 3 pi (post
infection), 3–6 mice per group were euthanized by CO2 narcosis,
lungs were extracted, suspended in 4 volumes by weight of cold
sterile PBS (phosphate buffered saline) and homogenized. Virus
titre was determined by plaque assay and quantified as PFU/gram
(PFU/g). IFN-b concentration was determined by ELISA assay
using the manufacturer’s protocol (PBL biosciences, New Jersey,
USA) with subtraction of mock PBS-infected lung values.
Immunofluorescence and H &E staining of the mouse
lung
Lung staining was performed as described previously [45].
Briefly, mice were infected intranasally with 1610
5 PFU in a
50 mL volume of the rHK NS mutants expressing NS1 mutations
D2N
{, L98S, M106I or M106I+L98S, as well as the rHK-wt virus.
Lungs were collected at 2 and 6 days pi, venously perfused with
PBS, and then inflated and fixed with 3.7% formaldehyde.
Following 24 h fixation at 4uC, the buffer was replaced with 20%
sucrose for 24 h at 4uC, and then frozen and cut into 7 uM
sections. Viral antigen was detected by incubating the sections
with anti-HK primary rabbit antibody diluted (1/1,000) in
antibody buffer (10 mM PBS containing 3% bovine serum
albumin and 0.3% Triton X-100). After washing with 10 mM
PBS, the slides were incubated with Cy3-conjugated donkey anti-
rabbit secondary antibody (Jackson ImmunoResearch laboratories
Inc., ME) diluted (1/800) in the antibody buffer. The slides were
then washed, and nuclei were stained by incubation with 100 ml
Hoechst (0.2 mg/ml). Images were taken at 206 magnification
using an Olympus BX50 microscope and processed in parallel
manner using Adobe Photoshop version 7.0. For lung pathological
examination, frozen sections were stained with hematoxylin and
eosin (H&E), and examined under light microscopy for histopath-
ologic changes. The images were obtained on a Nikon microscope
using a 106objective lens.
In vitro growth of recombinant HK NS mutants
To determine the effect of MA NS1 mutations on viral
replication in mouse cells, confluent M1 cells were left untreated
or treated with 1000 U/mL recombinant mouse IFN-b for
24 hours, then infected at a multiplicity of infection (MOI) of
0.02 with rHK NS mutants as well as rHK-wt virus in triplicate
(n=3). Cells were infected by incubation with virus for 45 minutes
at 37uC, and then supplemented with serum-free MEM (minimal
essential media) in the presence of 0.5 mg/mL TPCK-trypsin
(Thermo Fisher Scientific, Canada). Supernatants were collected
at 12, 24, 48 and 72 hpi (hours post infection), and virus titre was
determined by plaque assay in duplicate.
Measurement of influenza viral mRNA by quantitative
PCR
M1 cells were infected with rHK NS mutant or rHK- wt viruses
at a MOI of 2. Forty-five minutes after incubation at 37uC, the
cells were washed once with PBS and fresh serum-free MEM was
added. Then, the cells were washed twice by cold PBS before
collection at 8 hpi. Total RNA was isolated from infected cells by
using RNeasy Protect Mini Kit (QIAGEN). 500 ng of total RNA,
which corresponds to equal cell equivalents, was reverse
transcribed using an oligo(dT) primer for viral mRNA. Real-time
PCR (qPCR) was performed with SYBR GreenER qPCR
SuperMix (Bio-Rad Laboratories (Canada) Ltd., Mississuaga,
Ontario) and the Bio-Rad Chromo 4 Real-Time PCR Detector
(Bio-Rad Laboratories (Canada) Ltd., Mississuaga, Ontario).
Briefly, 2 ml of 10 fold diluted cDNA was added to the qPCR
reaction mixture [10 ml SYBR GreenER qPCR SuperMix (26),
1 ml each of forward and reverse gene specific primer (5 pM),
7.5 ml double-distilled water]. The cycle conditions of qPCR were
95uC 3 min, followed by 40 cycles of 95uC3 0s ,5 5 uC 30 s and
72uC 30 s, then extended at 72uC for 3 min. Results were
analyzed by DD CT methods and normalized to the b-actin gene.
Each experiment was performed for three biological repeats and
two technical replicates. Real-time PCR primers for A/Hong
Kong/1/1968 (H3N2) NS1, NP, and M1 mRNA were matched in
PCR efficiency (within 610%) with mouse b-actin forward:
AAATCGTGCGTGACATCAAA, and mouse b-actin reverse:
AAGGAAGGCTGGAAAAGAGC primers, and were as follows:
NP forward: TGGAGAGGTGAAAATGGACG, NP reverse:
TTTCCTGGGTTCCGACTTTC NS1 forward: ACCATTG-
CCTTCTCTTCCAG, NS1 reverse: TCCCATTCTCATTA-
CTGCTTCC, M1 forward: GTACGTTCTCTCTATCGTC-
CC, M1 reverse: GTCTTGTCTTTAGCCATTCCA.
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To compare the effect of mutant NS gene segments on viral
polymerase activity, a luciferase reporter minigenome assay was
used as per previous protocol [5]. Briefly, 96 well plates of HEK
293-T cells were transfected with 0.06 ug of phPOL1-NP-LUC
reporter plasmid [5], 0.06 ug of the internal control luciferase
expression plasmid PRL-SV40 (Promega), 0.06 ug of each pLLB
HK-wt PB2, PB1, PA and NP, and 0.06 ug of either HK-wt or
mutant pLLB NS plasmids or empty pLLB vector, using 0.5 uL
lipofectamine 2000 in 100 uL Opti-MEM (Invitrogen, Burlington,
Ontario). The HK-wt NS plasmid was mutated using PCR
mutagenesis to express NS1 protein alone by disrupting the 39
NS2/NEP splice site with a synonymous mutation as well as
introducing a stop codon at position 14 in the NS2 reading frame
using the following primers: NS1-forward: GCCTTCTCT-
TCCCGGACATACTATAGAGGATGTCA, and NS1 rever-
se: TGACATCCTCTATAGTATGTCCGGGAAGAGAAGGC.
To express NS2/NEP protein alone the HK-wt NS plasmid was
mutated using PCR mutagenesis to delete the NS intron using the
following primers: NS2-forward: ACACTGTGTCAAGTTTT-
CAGGACATACTATTGAGGATGTC, and NS2 reverse: GA-
CATCCTCAATAGTATGTCCTGAAAACTTGACACAGTG-
T. Forty-eight hours following transfection, luminescence was
measured using the Promega Dual-Glo Luciferase Assay System
with a Glomax Multi Detection System, Model 9301-010 (Fisher
Scientific, Nepean, Ontario) according to the manufacturer’s
protocol. Data represent the average 6 standard deviation of
relative luciferase activities (ratio of firefly and renilla luciferase
luminescence for 3 or 4 replicate experiments).
Viral protein synthesis in vitro
M1 cell monolayers were treated with 200 U/ml of recombi-
nant murine IFN-b (Sigma, St. Louis, USA) in serum-free MEM
for 24 hours or left untreated. Following treatment, the monolay-
ers were washed twice with 16 PBS then infected with the
recombinant HK NS mutants as well as rHK-wt (MOI=2) for
30 min at 37uC. Following infection, the cells were incubated with
serum-free media in the absence of trypsin. At 2, 4, 6, and 8 hpi,
cell monolayers were washed with PBS then the media was
replaced with serum-free Met- Cys- DMEM (Gibco, Carlsbad,
USA) containing 80 mCi/mL
35S-labeled cysteine and methionine
(Express tag, Perkin Elmer, Canada) for a 1 hour pulse at 37uC,
before the cell lysate was collected in 0.5 mL 16 SDS (sodium
dodecyl sulphate) buffer. Samples were then used for SDS PAGE
electrophoresis and autoradiography. The experiment was per-
formed in duplicate, with representative data shown. Densitometry
was performed on two independent experiments by analysis of
pixel density (UNScan-it 6.1), and presented as the values relative
to rHK-wt 6 SE.
Pulse chase assay
M1 cell monolayers in 12-well plates were washed twice with
16 PBS then infected with the recombinant NS mutants D2N
{,
D125G, M106V+M124I and R227K
{ as well as rHK-wt
(MOI=2) for 30 min at 37uC. Monolayers were pulse labeled at
8 hpi, after washing with PBS, with serum-free Met- Cys- DMEM
(Gibco, Carlsbad, USA) containing 80 mCi/mL
35S-labeled
cysteine and methionine (Express tag, Perkin Elmer, Canada) for
a 1 hour at 37uC. Cell lysates was either collected in 0.225 mL 16
SDS (sodium dodecyl sulphate) buffer (pulse samples) or the cells
were washed twice with 16PBS then the media was replaced with
serum-free MEM supplemented with an additional 15 mg/L cold
methionine and cysteine (chase samples). Chase sample cell lysates
were collected at 1 and 3 hours following pulse labeling (10 and
12 hpi) in 0.225 mL 1X SDS buffer. Samples were then used for
SDS PAGE electrophoresis and autoradiography. For quantifica-
tion of M1 and NS1 band intensity, each gel was exposed to a
PhosphorScreen (GE healthsciences) that was then read on a
Typhoon Image Analyzer (GE healthsciences). Relative band
intensity was quantified using Imagequant software (GE healths-
ciences) and calculated as the average 6 standard deviation of the
ratio of M1 to NS1 protein in each condition. The experiment was
performed in triplicate, with representative data shown. Statistical
analysis was performed, however no virus induced statistically
significant (p,0.05) difference in the ratio of M1:NS1 for pulse
compared to chase.
NS1-CPSF30 F2F3 binding assay
The CPSF30-F2F3 domain responsible for the binding of CPSF
to NS1 as well as each HK-wt and mutant NS1 protein were
radiolabeled and synthesized as described previously using the
TnT T7 Quick-Coupled Transcription/Translation System (Pro-
mega) [65]. The F2F3 fragment was synthesized as a flag-tagged
construct under control of the T7 promoter in the pET17b vector.
All NS mutants and HK-wt NS expression were also expressed
with the T7 promoter in the bi-directional pLLB plasmid. Briefly,
0.5 ug plasmid DNA (or empty pLLB vector) was mixed with 10
uCi
35S-labeled methionine+cysteine (Express
35S Protein Label-
ing Mix, Perkin Elmer) and 40 uL TnT master mix in a 50 uL
total volume. The mixture was incubated 90 minutes in a 30uC
water bath then stored at 220uC until use. To verify equal
expression of the NS1 proteins and expression of the F2F3-FLAG
fragment, an aliquot of each TnT reaction was resuspended in 3X
SDS buffer, then subject to SDS-PAGE electrophoresis and
autoradiography (Fig. 5b). To assess NS1 binding to F2F3-FLAG,
equal volumes (10 uL of TnT reaction) of each radiolabeled NS1
(or empty pLLB vector TnT reaction) were incubated with 10 uL
of radiolabeled F2F3-FLAG in the presence of Protein G
Dynabeads (Invitrogen, Burlington, Ontario) pre-incubated with
rabbit a-FLAG M2 (Sigma) antibody in NP-40 lysis buffer. The
pulldown assay was performed as per the manufacturor’s protocol
of Protein G Dynabeads. Briefly, the proteins were incubated with
the antibody-conjugated beads overnight at 4uC while rocking,
then were washed with NP-40 lysis buffer four times using a
magnetic rack. Following wash, the beads were resuspended in
50 uL 1xSDS buffer and heated at 100uC for 1 minute before
analyzed by SDS-PAGE electrophoresis and autoradiography. For
quantification of band intensity, each gel was exposed to a
PhosphorScreen (GE healthsciences) that was then read on a
Typhoon Image Analyzer (GE healthsciences). Relative band
intensity was quantified using Imagequant software (GE healths-
ciences) for a total of three independent experiments, and
calculated as the average 6 standard deviation of the % value
relative to HK-wt NS1. The absence of non-specific binding of the
NS1 protein (wt or mutant) to the a-FLAG M2-conjugated beads
was shown by pull-down in the absence of F2F3-FLAG protein
(Fig. S1).
Nucleotide sequencing
Nucleotide sequencing was done as described previously for
RT-PCR amplified genome segment 8 (Ping, 2011) (Genbank
accession numbers CY044265, CY044273, CY045720, HM641
216, CY033125, HM641215, CY044281, CY045736, CY033533,
CY033541, CY033549 and JN896299).
Statistical analysis
Statistical significance was measured using the student t-test
(Microsoft Excel, 2007) or paired student t-test (GraphPad Prism
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indicated) and two-tailed significance with a probability of #0.05
considered as statistically significant. Values were calculated as
means 6 standard deviation with the exception of Figure 9c–d,
where values were calculated as means 6 standard error from two
independent experiments.
Supporting Information
Figure S1 Recombinant NS1 proteins do not show non-
specific binding to a-FLAG M2 antibody bound Protein G
Dynabeads. NS1 proteins (wt or mutant) in the absence of
CPSF30-F2F3-FLAG were not pulled-down using a-FLAG M2
antibody bound to Protein G Dynabeads relative to a control pull
down in the presence of CPSF30-F2F3-FLAG (first lane). Samples
were prepared and analyzed as described in methods.
(TIF)
Figure S2 Effect of NS (NS1 +NS2/NEP) and individual
NS1 and NS2/NEP proteins on RNA polymerase activity
in the luciferase mini-genome assay. Viral RNA polymer-
ase activity was measured in HEK 293-T cells expressing HK-wt
NS (NS1+NS2/NEP proteins) as well as individual NS1 or NS2/
NEP proteins, or empty vector control, in combination with HK-
wt PB2, PB1, PA, NP, and the NP promoter driven firefly
luciferase mini-genome. Polymerase activity is shown as the ratio
of firefly to renilla luciferase standardized to the vector control
(100%), and presented as means 6 SD for 4 experiments as well as
the corresponding renilla luciferase activities (*p,0.05, **p,0.01
***p,0.001, student’s t test).
(TIF)
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